ALT · Altimmune, Inc. · Executive Compensation

$2.12 -0.05 (-2.30%) At close · Oct 23

Russell 2000 member Rebalance outlook locked

Market Cap

$412.38M

194.52M

Volume · Oct 23 2.6M Avg daily vol (3M) 4.32M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vipin K. Garg	Chief Executive Officer	$514,375	—	—	$536,705	$354,063	$29,258	$1,434,401
Scott Harris	Chief Medical Officer	$377,092	—	—	$92,991	$188,700	$11,400	$670,183
Scot Roberts	Chief Scientific Officer	$348,583	—	—	$92,991	$175,000	$11,400	$627,974
William Brown	Chief Financial Officer	$339,488	—	—	$92,991	$169,950	$19,678	$622,106
Sybil Tasker	M.D., MPH Former Chief Medical Officer	—	—	—	—	—	—	—

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vipin K. Garg	Chief Executive Officer	$500,000	—	—	—	$248,016	$66,631	$814,647
William Brown	Chief Financial Officer	$192,500	—	—	$151,564	$89,627	$190,656	$624,347
Scot Roberts	Chief Scientific Officer	$316,000	—	—	$85,605	$33,831	$12,825	$448,261
Scott Harris	Chief Medical Officer	$115,032	—	—	$171,325	$95,318	$1,233	$382,908
Sybil Tasker	M.D., MPH Former Chief Medical Officer	$203,500	—	—	$146,103	—	$6,912	$356,515
William Enright	Former Chief Executive Officer	—	—	—	—	—	—	—
Elizabeth A. Czerepak	Former Chief Financial Officer	—	—	—	—	—	—	—

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vipin K. Garg	Chief Executive Officer	$43,590	$100,000	$1,159,236	$887,107	—	$31	$2,189,964
William Enright	Former Chief Executive Officer	$410,667	$184,800	—	$34,463	—	$7,776	$637,706
Sybil Tasker	Former Chief Medical Officer	$397,000	$125,055	—	$16,705	—	$7,571	$546,331
William Brown	Chief Financial Officer	—	—	—	—	—	$216,000	$216,000
Elizabeth A. Czerepak	Former Chief Financial Officer	$126,923	—	—	—	—	$5,076	$131,999
Scott Harris	Chief Medical Officer	—	—	—	—	—	—	—

Executive changes

Person	Role	Change	Effective	Filed
Richard Menziuso	Vice President, Global Controller and Principal Accounting Officer	Appointed	2026-09-29	2026-09-29
Jerry Durso	President and Chief Executive Officer	Appointed	2026-01-01	2025-12-01
Jerome Durso	President and Chief Executive Officer	Appointed	2026-01-01	2025-12-01
Christophe Arbet-Engels, MD, PhD	Chief Medical Officer	Appointed	2025-10-01	2025-10-03
Teri Lawver	Board of Directors	Appointed	—	2025-02-27
Jerry Durso	Board of Directors	Appointed	—	2025-02-27
Jerome Durso	director of the Board	Appointed	2025-02-24	2025-02-25
Teri Lawver	director of the Board	Appointed	2025-02-24	2025-02-25
Greg Weaver	Chief Financial Officer (CFO)	Appointed	2024-11-11	2024-11-12
Gregory Weaver	Chief Financial Officer	Appointed	2024-11-11	2024-11-12
Andrew Shutterly	acting Chief Financial Officer, "principal financial officer" and "principal accounting officer"	Appointed	2024-06-25	2024-06-26
Catherine Sohn	director	Appointed	2023-03-23	2023-03-27

Leadership

Jerome Durso CEO, Board Member
Vipin K. Garg CEO
William Enright CEO
Elizabeth A. Czerepak CFO
Richard I. Eisenstadt CFO
Richard Menziuso Chief Accounting Officer
Catherine Angell Sohn Board Member
Catherine Sohn Board Member
Diane Jorkasky, M.D. Board Member
Jerry Durso Board Member
Teri Lawver Board Member

Key facts CIK 1326190 CUSIP 02155H200 13F (30d) 23 filings 23 filers Visit website Investor relations